Skip to main content
Premium Trial:

Request an Annual Quote

VC Spending on -omics Shops Slides 25 Percent in Q1, But Proteomics, Genomics Grows

NEW YORK (GenomeWeb News) — The flow of venture capital to the multivariate -omics disciplines slowed by more than a quarter in the first three months of 2007 compared to the same period in 2006, according to a GenomeWeb Daily News roundup of companies that disclosed receiving investments.
However, private equity financing to companies that sell or provide services for genomic or proteomic applications increased year over year.
VC investment in all privately held -omics companies covered by GenomeWeb Daily News fell nearly 26 percent to $63.2 million spread among five deals in the first quarter of 2007 from $79.6 million spread among nine deals in the same period last year.
But companies dealing in genomic wares saw a 138-percent increase in VC investment, netting $20.5 million in the first quarter of 2007 compared with $8.6 million year over year.
Also, investment in proteomic tool companies grew 150 percent to $48.7 million from $19 million in the first quarter last year.
Companies closing private-equity rounds in the first quarter of 2007 were Genizon BioSciencesAutoGenomicsDevgen, GenTel BioSciences, and Oxford Genome Sciences.
Companies closing private-equity rounds in the first quarter of 2006 were DeltaDotBioTroveCoda Genomics, Precision TherapeuticsDecision Biomarkers, EraGenIntrexonGuava Technologies, and Cetek.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.